Insect peptide CopA3-induced protein degradation of p27Kip1 stimulates proliferation and protects neuronal cells from apoptosis

Biochemical and Biophysical Research Communications

Volumn 437, Issue 1, 2013, Pages 35-40

  Nam, Seung Taek ^a   Kim, Dae Hong ^a   Lee, Min Bum ^a   Nam, Hyo Jung ^a   Kang, Jin Ku ^a   Park, Mi Jung ^a   Lee, Ik Hwan ^a   Seok, Heon ^b   Lee, Dong Gun ^c   Hwang, Jae Sam ^d   Kim, Ho ^a  

^a Daejin University   (South Korea)

^b Jungwon University   (South Korea)

^c Kyungpook National University   (South Korea)

^d National Institute of Animal Science   (South Korea)

Author keywords

Apoptosis; Caspase 3; Cell proliferation; Cell viability; Insect peptide; Mouse neural stem cells; Neuronal cells; Neuroprotective activity; Neurotropic factor; P27Kip1

Indexed keywords

CASPASE 3; COPA3 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; INSECT PROTEIN; NEUROTROPIC AGENT; OKADAIC ACID; OXIDOPAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGENICITY; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; MOUSE; NERVE CELL; NEURAL STEM CELL; NEUROBLASTOMA; NEUROBLASTOMA CELL; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE; 6-HYDROXY DOPAMINE; 6-OHDA; APOPTOSIS; CASPASE-3; CELL PROLIFERATION; CELL VIABILITY; INSECT PEPTIDE; MNSCS; MOUSE NEURAL STEM CELLS; MTT; NEURONAL CELLS; NEUROPROTECTIVE ACTIVITY; NEUROTROPIC FACTOR; OA; OKADAIC ACID; P27KIP1;

AMINO ACID SEQUENCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; APOPTOSIS; BEETLES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HALF-LIFE; HUMANS; INSECT PROTEINS; MICE; MOLECULAR SEQUENCE DATA; NEURAL STEM CELLS; NEUROBLASTOMA; NEURONS; NEUROPROTECTIVE AGENTS; OKADAIC ACID; OXIDOPAMINE; PEPTIDES; PROTEOLYSIS;

ADENOVIRIDAE; HEXAPODA;

EID: 84880511814     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.06.031     Document Type: Article

References (26)

1. J.S. Hwang, J. Lee, Y.J. Kim, H.S. Bang, E.Y. Yun, S.R. Kim, H.J. Suh, B.R. Kang, S.H. Nam, J.P. Jeon, I. Kim, D.G. Lee, Isolation and characterization of a defensin-like peptide (coprisin) from the dung beetle, Copris tripartitus, Int. J. Pept. 2009 (2009).
2. Kang J.K., Hwang J.S., Nam H.J., Ahn K.J., Seok H., Kim S.K., Yun E.Y., Pothoulakis C., Lamont J.T., Kim H. The insect peptide coprisin prevents Clostridium difficile-mediated acute inflammation and mucosal damage through selective antimicrobial activity. Antimicrob. Agents Chemother. 2011, 55:4850-4857.
3. Kang B.R., Kim H., Nam S.H., Yun E.Y., Kim S.R., Ahn M.Y., Chang J.S., Hwang J.S. CopA3 peptide from Copris tripartitus induces apoptosis in human leukemia cells via a caspase-independent pathway. BMB Rep. 2012, 45:85-90.
4. Nam H.J., Oh A.R., Nam S.T., Kang J.K., Chang J.S., Kim D.H., Lee J.H., Hwang J.S., Shong K.E., Park M.J., Seok H., Kim H. The insect peptide CopA3 inhibits lipopolysaccharide-induced macrophage activation. J. Pept. Sci. 2012, 18:650-656.
5. Wang P., Xie Z.H., Guo Y.J., Zhao C.P., Jiang H., Song Y., Zhu Z.Y., Lai C., Xu S.L., Bi J.Z. VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer's disease. Biochem. Biophys. Res. Commun. 2011, 411:620-626.
6. Choi J.S., Lee M.S., Jeong J.W. Ethyl pyruvate has a neuroprotective effect through activation of extracellular signal-regulated kinase in Parkinson's disease model. Biochem. Biophys. Res. Commun. 2010, 394:854-858.
7. da Rocha M.D., Viegas F.P., Campos H.C., Nicastro P.C., Fossaluzza P.C., Fraga C.A., Barreiro E.J., Viegas C. The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders II: Alzheimer's disease. CNS Neurol. Disord. Drug Targets 2011, 10:251-270.
8. Sharma N.K., Sethy N.K., Meena R.N., Ilavazhagan G., Das M., Bhargava K. Activity-depende6nt neuroprotective protein (ADNP)-derived peptide (NAP) ameliorates hypobaric hypoxia induced oxidative stress in rat brain. Peptides 2011, 32:1217-1224.
9. Liu Z., Naranjo A., Thiele C.J. CASZ1b, the short isoform of CASZ1 gene, coexpresses with CASZ1a during neurogenesis and suppresses neuroblastoma cell growth. PLoS One 2011, 6:e18557.
10. Eggert A., Ikegaki N., Liu X., Chou T.T., Lee V.M., Trojanowski J.Q., Brodeur G.M. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells. Oncogene 2000, 19:2043-2051.
11. Yoo J., Seo J.J., Eom J.H., Hwang D.Y. Effects of stromal cell-derived factor 1alpha delivered at different phases of transient focal ischemia in rats. Neuroscience 2012, 209:171-186.
12. Kim H., Rhee S.H., Kokkotou E., Na X., Savidge T., Moyer M.P., Pothoulakis C., LaMont J.T. Clostridium difficile toxin A regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAPK. J. Biol. Chem. 2005, 280:21237-21245.
13. Leuba G., Walzer C., Vernay A., Carnal B., Kraftsik R., Piotton F., Marin P., Bouras C., Savioz A. Postsynaptic density protein PSD-95 expression in Alzheimer's disease and okadaic acid induced neuritic retraction. Neurobiol. Dis. 2008, 30:408-419.
14. Arias E., Gallego-Sandin S., Villarroya M., Garcia A.G., Lopez M.G. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. J. Pharmacol. Exp. Ther. 2005, 315:1346-1353.
15. Yi K.D., Covey D.F., Simpkins J.W. Mechanism of okadaic acid-induced neuronal death and the effect of estrogens. J. Neurochem. 2009, 108:732-740.
16. Li Y., Luo F., Wei L., Liu Z., Xu P. Knockdown of glycogen synthase kinase 3 beta attenuates 6-hydroxydopamine-induced apoptosis in SH-SY5Y cells. Neurosci. Lett. 2011, 487:41-46.
17. Kwon S.H., Hong S.I., Jung Y.H., Kim M.J., Kim S.Y., Kim H.C., Lee S.Y., Jang C.G. Lonicera japonica THUNB. protects 6-hydroxydopamine-induced neurotoxicity by inhibiting activation of MAPKs, PI3K/Akt, and NF-kappaB in SH-SY5Y cells. Food Chem. Toxicol. 2011, 50:797-807.
18. Munoz U., Bartolome F., Bermejo F., Martin-Requero A. Enhanced proteasome-dependent degradation of the CDK inhibitor p27(kip1) in immortalized lymphocytes from Alzheimer's dementia patients. Neurobiol. Aging 2008, 29:1474-1484.
19. Pamarthy D., Tan M., Wu M., Chen J., Yang D., Wang S., Zhang H., Sun Y. p27 degradation by an ellipticinium series of compound via ubiquitin-proteasome pathway. Cancer Biol. Ther. 2007, 6:360-366.
20. Qiu J., Takagi Y., Harada J., Topalkara K., Wang Y., Sims J.R., Zheng G., Huang P., Ling Y., Scadden D.T., Moskowitz M.A., Cheng T. p27Kip1 constrains proliferation of neural progenitor cells in adult brain under homeostatic and ischemic conditions. Stem Cells 2009, 27:920-927.
21. Gozes I., Stewart A., Morimoto B., Fox A., Sutherland K., Schmeche D. Addressing Alzheimer's disease tangles: from NAP to AL-108. Curr. Alzheimer Res. 2009, 6:455-460.
22. Gozes I., Zaltzman R., Hauser J., Brenneman D.E., Shohami E., Hill J.M. The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury. Curr. Alzheimer Res. 2005, 2:149-153.
23. Kumral A., Yesilirmak D.C., Sonmez U., Baskin H., Tugyan K., Yilmaz O., Genc S., Gokmen N., Genc K., Duman N., Ozkan H. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats. Brain Res. 2006, 1115:169-178.
24. Greggio S., Rosa R.M., Dolganov A., de Oliveira I.M., Menegat F.D., Henriques J.A., Dacosta J.C. NAP prevents hippocampal oxidative damage in neonatal rats subjected to hypoxia-induced seizures. Neurobiol. Dis. 2009, 36:435-444.
25. Shiryaev N., Jouroukhin Y., Giladi E., Polyzoidou E., Grigoriadis N.C., Rosenmann H., Gozes I. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model. Neurobiol. Dis. 2009, 34:381-388.
26. Arakawa T., Hirano A., Shiraki K., Niikura T., Kita Y. Advances in characterization of neuroprotective peptide, humanin. Curr. Med. Chem. 2011, 18:5554-5563.